Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Subtyping of circulating exosome-bound amyloid β reflects brain plaque deposition.

Lim CZJ, Zhang Y, Chen Y, Zhao H, Stephenson MC, Ho NRY, Chen Y, Chung J, Reilhac A, Loh TP, Chen CLH, Shao H.

Nat Commun. 2019 Mar 8;10(1):1144. doi: 10.1038/s41467-019-09030-2.

2.

The Health and Well-Being of Caregivers of Technologically Dependent Children.

Chan YH, Lim CZ, Bautista D, Malhotra R, Østbye T.

Glob Pediatr Health. 2019 Jan 23;6:2333794X18823000. doi: 10.1177/2333794X18823000. eCollection 2019.

3.

Appropriateness of blood culture: A comparison of practices between the emergency department and general wards.

Choi EC, Chia YH, Koh YQ, Lim CZQ, Lim JC, Ooi SBS, Ibrahim I, Kuan WS.

Infect Dis Health. 2019 Feb;24(1):49-55. doi: 10.1016/j.idh.2018.10.003. Epub 2018 Nov 26.

PMID:
30541693
4.

Olanzapine-induced Cataract in a Teenage Girl.

Lim CZ, Sonny Teo KS, Tai E.

Cureus. 2018 Apr 30;10(4):e2553. doi: 10.7759/cureus.2553.

5.

Functional Characterization of D9, a Novel Deazaneplanocin A (DZNep) Analog, in Targeting Acute Myeloid Leukemia (AML).

Jiang X, Lim CZ, Li Z, Lee PL, Yatim SM, Guan P, Li J, Zhou J, Pan J, Chng WJ, Chai CL, Yu Q.

PLoS One. 2015 Apr 30;10(4):e0122983. doi: 10.1371/journal.pone.0122983. eCollection 2015.

6.

3-Deazaneplanocin A and neplanocin A analogues and their effects on apoptotic cell death.

Tam EK, Nguyen TM, Lim CZ, Lee PL, Li Z, Jiang X, Santhanakrishnan S, Tan TW, Goh YL, Wong SY, Yang H, Ong EH, Hill J, Yu Q, Chai CL.

ChemMedChem. 2015 Jan;10(1):173-82. doi: 10.1002/cmdc.201402315. Epub 2014 Oct 15.

PMID:
25319940
7.

PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy.

Tan J, Li Z, Lee PL, Guan P, Aau MY, Lee ST, Feng M, Lim CZ, Lee EY, Wee ZN, Lim YC, Karuturi RK, Yu Q.

Cancer Discov. 2013 Oct;3(10):1156-71. doi: 10.1158/2159-8290.CD-12-0595. Epub 2013 Jul 25.

8.

Polycomb protein EZH2 regulates cancer cell fate decision in response to DNA damage.

Wu Z, Lee ST, Qiao Y, Li Z, Lee PL, Lee YJ, Jiang X, Tan J, Aau M, Lim CZ, Yu Q.

Cell Death Differ. 2011 Nov;18(11):1771-9. doi: 10.1038/cdd.2011.48. Epub 2011 May 6.

Supplemental Content

Support Center